Aion Therapeutic (XCNQ:AION) Total Stockholders Equity : C$1.03 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Total Stockholders Equity?

Aion Therapeutic's Total Stockholders Equity for the quarter that ended in Jan. 2024 was C$1.03 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Aion Therapeutic's Book Value per Share for the quarter that ended in Jan. 2024 was C$0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Aion Therapeutic's Debt-to-Equity for the quarter that ended in Jan. 2024 was 1.97.

Aion Therapeutic Total Stockholders Equity Historical Data

The historical data trend for Aion Therapeutic's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Total Stockholders Equity Chart

Aion Therapeutic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Total Stockholders Equity

Get a 7-Day Free Trial

2.64

2.13

0.40

-2.41

-2.73

Aion Therapeutic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															-1.86	-2.73	-2.72	-2.69	1.03

Aion Therapeutic (XCNQ:AION) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Aion Therapeutic's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1.033	-	0)	/	411.549
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Aion Therapeutic's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.035	+	0)	/	1.033
	=	1.97

Aion Therapeutic Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic (XCNQ:AION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Executives

Ismail Abdul Fattah

Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines